| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25fc15a160e627c2c4c948eaebeb6312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74cf55baa9fd517bbe4b24edcef25171
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0613b28dc52e05867d7800fc7cb2298a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8358bf79b018b41287749f2e251c811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c804d2bb21e41ed5773325a1b304798
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96b849270f0f52167b284a7f14c843b0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-126 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-12 |
| filingDate |
2003-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3190fb42b1ffaba3b6bdd32a5921bd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ab03f17c378d63c65598de0de56d575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c228ab2aa89413250fc6abe6a91b437a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_052f2e2221d31973c6d2e119d0f9efc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_536cc58738bc504f396a7532395ee1fc |
| publicationDate |
2003-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03104265-A1 |
| titleOfInvention |
Compound having glycine transporter inhibition activity |
| abstract |
A compound of the formula: [wherein each of R 1 , R 2 and R 3 nrepresents a hydrogen atom or a methyl group; R 4 represents a hydrogennatom or a hydroxyl group; and R 5 represents a hydrogen atom or a methylngroup] is a novel physiologically active substance exhibiting an inhibitionnactivity to the glycine transporter of glia cells, and is useful as a therapeuticnagent for comprehensive ataxia. |
| priorityDate |
2002-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |